---
schema_version: "secwatch.filing_event.v1"
accession: "0000950103-25-009253"
form_type: "8-K"
ticker: "AMRX"
cik: "0001723128"
company_name: "Amneal Pharmaceuticals, Inc."
filed_at: "2025-07-24T23:59:59+00:00"
generated_at: "2026-05-18T02:26:11.079140+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Amneal prices $600M 6.875% senior secured notes due 2032, upsizes term loan to $2.1B

## Summary
- $600M notes priced at par with 6.875% coupon, due 2032; downsized from $750M due to term loan increase.
- New term B loans upsized to $2.1B from $1.8B, seven-year maturity.
- Proceeds to refinance existing term B loans in full and repay ABL facility.
- Closing expected August 1, 2025, subject to customary conditions.

## SEC filing metadata
- accession: 0000950103-25-009253
- form_type: 8-K
- ticker: AMRX
- cik: 0001723128
- company_name: Amneal Pharmaceuticals, Inc.
- filed_at: 2025-07-24T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1723128/000095010325009253/0000950103-25-009253-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1723128/000095010325009253/dp232033_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950103-25-009253
- JSON: https://secwatch.observer/filing/0000950103-25-009253.json
- Plain text: https://secwatch.observer/filing/0000950103-25-009253.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.